Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Guidances On Actual Use Studies, Switches Will Clarify Agency Processes

This article was originally published in The Tan Sheet

Executive Summary

A guidance on conducting actual use trials for Rx-to-OTC switch candidates is under development, according to FDA Office of New Drugs Director John Jenkins, MD
Advertisement

Related Content

Medicare HSAs May Compel Drug Industry To Rethink Position On OTCs
Medicare HSAs May Compel Drug Industry To Rethink Position On OTCs
Medicare HSAs May Compel Drug Industry To Rethink Position On OTCs
FDA Office Of New Drug Restructuring To Include OTC Resource Reallocation
FDA Office Of New Drug Restructuring To Include OTC Resource Reallocation
FDA Office Of New Drug Restructuring To Include OTC Resource Reallocation
FDA Office Of New Drug Restructuring To Include OTC Resource Reallocation
CHPA 2004 Goals: Improving Switch Process, Launching Education Foundation
Supplement Labeling Guide Set For Release This Year – FDA Guidance Agenda
Supplement Labeling Guide Set For Release This Year – FDA Guidance Agenda

Topics

Advertisement
UsernamePublicRestriction

Register

PS096611

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel